Reply
- PMID: 35532942
- DOI: 10.1002/hep.32565
Reply
References
REFERENCES
-
- Younossi ZM, Paik JM, Al Shabeeb R, Golabi P, Younossi I, Henry L. Are there outcome differences between NAFLD and metabolic associated fatty liver disease? Hepatology. 2022. https://doi.org/10.1002/hep.32499
-
- Fouad Y, Abdel Dayem WA, Mehrez M. Letter to the editor: apples should be compared with apples. Hepatology. 2022. https://doi.org/10.1002/hep.32564
-
- Attia D, Gomaa A, Abdel Aleem S. Letter to the editor: Pitfalls in the outcome differences between NAFLD and MAFLD. Hepatology. 2022. https://doi.org/10.1002/hep.32563
-
- Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202-9.
-
- Younossi ZM, Stepanova M, Ong J, Yilmaz Y, Duseja A, Eguchi Y, et al. Effects of alcohol consumption and metabolic syndrome on mortality in patients with nonalcoholic and alcohol-related fatty liver disease. Clin Gastroenterol Hepatol. 2019;17(8):1625-33.e1.
LinkOut - more resources
Full Text Sources